삼성서울병원
Language
CHINESE
KOREAN
RUSSIAN
Contact Us
글로벌 네비게이션
About SMC
Patients
Departments
Appointments
Research
Education
Overview
SMC President
Mission & Vision
Facts & Statistics
Major Performances
Infrastructure
SMC Network
SMC News
Contact Us
Location
Parking
Hotels & Transportation
Brochures & Downloads
ESG Report
International
Healthcare Center
Our services
Outpatient Services
Inpatient Services
For Patients Coming from Overseas
Special Services
Billing and Insurance
Convenient Facilities
Health Information
Find a Doctor
Departments
Specialized Centers
International Services
IHC Clinic
Clinic Hours
Health Promotion Center
What is Health Screening
Screening Programs
Contact Us
For Patients
For Health Screening
Physician’s Referral
FAQ
Precision Medicine
Research Institute for
Future medicine
Overview
Faculty and Staff
Institutes & Centers
Samsung Genome Institute
Medical Device
Research Center
Stem Cell & Regenerative
Medicine Institute
Bio Bank
Biostatistics and Clinical
Epidemiology Center
Laboratory Animal
Research Center
Clinical Trial Center
Institute for Refractory
Cancer Research
Research Area
Collaborate with Us
Sungkunkwan University
School of Medicine
SAIHST
Clinical Nursing Science
Faculty
Contact Us
SMC Training Programs
Observership Program
Customized Program
Advanced Clinical Skill
Course Program
Medical Student Clinical
Elective
Contact Us
HOME
About SMC
About SMC
Patients
Departments
Appointment
Research
Education
메뉴 펼치기
SMC News
User Guide
Contact Us
Location
Hotels & Transportation
HOME
About SMC
About SMC
Patients
Departments
Appointment
Research
Education
SMC News
Overview
SMC President
Mission & Vision
Facts & Statistics
Major performances
Infrastructure
SMC Network
SMC News
Contact Us
Location
Parking
Hotels & Transportation
Brochures & download
ESG Report
SMC research team publishes world’s first report on Avelumab for treatment of relapsed/ refractory extranodal NK/T-cell lymphoma: An open-label phase 2 study
Next
No Article.
Preview
No Article.
